Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy.
about
Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Atezolizumab: feasible second- ...... , safety and place in therapy.
@en
Atezolizumab: feasible second- ...... , safety and place in therapy.
@nl
type
label
Atezolizumab: feasible second- ...... , safety and place in therapy.
@en
Atezolizumab: feasible second- ...... , safety and place in therapy.
@nl
prefLabel
Atezolizumab: feasible second- ...... , safety and place in therapy.
@en
Atezolizumab: feasible second- ...... , safety and place in therapy.
@nl
P2093
P2860
P356
P1476
Atezolizumab: feasible second- ...... , safety and place in therapy.
@en
P2093
Fabrice Barlesi
Fanny Jean
Pascale Tomasini
P2860
P304
P356
10.1177/1758834017741074
P577
2017-12-19T00:00:00Z